Grupo 27
Farmacia Hospitalaria y Farmacogenómica
Publicaciones (412)
-
Ramos-Ruperez, E; Escudero-Vilaplana, V; Ruiz-Briones, P; Collado-Borrell, R; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Garcia-Gonzalez, X; Ibanez-Garcia, S; Perez-Ramirez, S; Zatarain-Nicolas, E; Herranz, A; Sanjurjo, M.
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Frontiers in Oncology. 2023; 13: Nº de citas: 2 [doi:10.3389/fonc.2023.1220305]
-
Yuste, I; Luciano, FC; Anaya, BJ; Sanz-Ruiz, P; Ribed-Sanchez, A; Gonzalez-Burgos, E; Serrano, DR.
Engineering 3D-Printed Advanced Healthcare Materials for Periprosthetic Joint Infections
Antibiotics-Basel. 2023; 12(8): [doi:10.3390/antibiotics12081229]
-
Bermejo-Gomez, A; Aguilera-Alonso, D; Rincon-Lopez, EM; Catalan-Alonso, P; Bardon-Cancho, EJ; Garcia-Morin, M; Manrique-Rodriguez, S; Navarro-Gomez, ML.
Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection
PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2023; 42(8): 290-292 [doi:10.1097/INF.0000000000003938]
-
Zapata-Cobo P; Salvador-Martín S; Velasco M; Palomino LM; Clemente S; Segarra O; Moreno-Álvarez A; Fernández-Lorenzo A; Pérez-Moneo B; Montraveta M; Sánchez C; Tolín M; Loverdos I; Fobelo MJ; Navas-López VM; Magallares L; García-Romero R; Sánchez-Hernández JG; Rodríguez A; Bossacoma F; Balboa MJ; Salcedo E; Sanjurjo-Sáez M; López-Fernández LA.
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
PHARMACOLOGICAL RESEARCH. 2023; 194: 106859-106859 Nº de citas: 5 [doi:10.1016/j.phrs.2023.106859]
-
Beatriz GC; María José O; Inés JL; Yolanda HG; Concha ÁD; Javier TS; Cecilia M FL.
Medication errors in children visiting pediatric emergency departments.
FARMACIA HOSPITALARIA. 2023; 47(4): [doi:10.1016/j.farma.2023.06.001]
-
Borras-Blasco J; Herráiz ER; Sánchez PL; Romero-Jimenez R; Navarro-Ruiz A; Sola NR.
Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis.
FARMACIA HOSPITALARIA. 2023; 47(4): 148-154 [doi:10.1016/j.farma.2023.03.007]
-
Beatriz, GC; Jose, OM; Ines, JL; Yolanda, HG; Concha, AD; Javier, TS; Cecilia, MFL.
Medication errors in children visiting pediatric emergency departments
FARMACIA HOSPITALARIA. 2023; 47(4): 141-147 Nº de citas: 8 [doi:10.1016/j.farma.2023.03.006]
-
Borras-Blasco, J; Herraiz, ER; Sanchez, PL; Romero-Jimenez, R; Navarro-Ruiz, A; Sola, NR.
Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis
FARMACIA HOSPITALARIA. 2023; 47(4): 148-154 [doi:10.1016/j.farma.2023.05.007]
-
Gonzalez, CGR; de Vega, EC; Martinez, SD; Minero, MV; Urbon, JMG; Manzorro, AG; Martinez, EFD; Sacristan, SC; Santiago, EB; Alonso, AH; de Paredes, PMG; Saez, MS.
A critical view on the current use of daptomycin in Spain: The daptomise study
Journal of Infection and Public Health. 2023; 16(7): 1115-1122 Nº de citas: 1 [doi:10.1016/j.jiph.2023.05.008]
-
Escudero-Vilaplana, V; Collado-Borrell, R; Martinez-Sagrera, PG; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Hoyo-Munoz, A; Gilarranz, YJ; Marzal-Alfaro, B; Herranz, A; Martin, M; Sanjurjo, M.
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7): 2855-2882 Nº de citas: 4 [doi:10.1007/s00432-022-04172-1]
-
Palomino-Cabrera, R; Tejerina, F; Molero-Salinas, A; Ferris, M; Veintimilla, C; Catalan, P; Macias, GR; Alonso, R; Munoz, P; de Viedma, DG; Perez-Lago, L.
Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023; 67(7): Nº de citas: 6 [doi:10.1128/aac.00266-23]
-
Martin, MT; Boquet, EM; Aznares, HN; Cortes, MDR; Gonzalez, CR; de las Hazas, JISL; Morillo-Verdugo, R.
2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus
FARMACIA HOSPITALARIA. 2023; 47(3): 113-120 Nº de citas: 2 [doi:10.1016/j.farma.2023.01.007]
-
Conde, MTM; Boquet, EM; Aznares, HN; Cortes, MDR; Gonzalez, CR; de las Hazas, JISL; Morillo-Verdugo, R.
[Translated article] 2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus
FARMACIA HOSPITALARIA. 2023; 47(3): 113-120 [doi:10.1016/j.farma.2023.04.008]
-
Ruiz-Briones, P; Escudero-Vilaplana, V; Collado-Borrell, R; Vicente-Valor, J; Alvarez, R; Villanueva-Bueno, C; Narrillos-Moraza, A; Herranz, A; Sanjurjo, M.
Possible heart failure caused by osimertinib in a lung cancer patient
JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023; 29(4): 1015-1020 Nº de citas: 4 [doi:10.1177/10781552221143787]
-
Arhip, L; Camblor, M; Breton, I; Motilla, M; Serrano-Moreno, C; Romero, RM; Lobato, E; Frias, L; Velasco, C; Carrascal, ML; Cuerda, C.
Implementation of a parenteral nutrition home care programme in a tertiary hospital
NUTRICION HOSPITALARIA. 2023; 40(3): 476-484 [doi:10.20960/nh.04494]
-
Garcia-Martin, E; Romero-Jimenez, RM; Baniandres-Rodriguez, O; Escudero-Vilaplana, V; Benedi-Gonzalez, J; Luna, PMD; Herranz-Alonso, A; Sanjurjo-Saez, M.
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors
EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; 31(5): 409-415 Nº de citas: 2 [doi:10.1136/ejhpharm-2022-003594]
-
Garcia-Gonzalez, X; Cubo, E; Simon-Vicente, L; Mariscal, N; Alcaraz, R; Aguado, L; Rivadeneyra-Posadas, J; Sanz-Solas, A; Saiz-Rodriguez, M.
Thermodynamical Analysis of the Formation of a-Si Ring Structures on Silicon Surface
Journal Of Personalized Medicine. 2023; 13(3): Nº de citas: 7 [doi:10.3390/jpm13030385]
-
Villanueva-Bueno, C; Montecatine-Alonso, E; Jimenez-Parrilla, F; Gonzalez-Lopez, M; Manrique-Rodriguez, S; Moreno-Ramos, F; Canete-Ramirez, C; Dolz, E; Garcia-Robles, A; Caro-Teller, JM; Moral-Pumarega, MT; Bergon-Sendin, E; Calvo, MTGT; Gallego-Fernandez, C; del Vayo-Benito, CA; Mejias-Trueba, M; Gil-Navarro, MV.
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice
Antibiotics-Basel. 2023; 12(3): Nº de citas: 2 [doi:10.3390/antibiotics12030602]